Needham & Company LLC Reiterates “Buy” Rating for Immunocore (NASDAQ:IMCR)
Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports. They presently have a $71.00 price objective on the stock. Needham & Company LLC’s target price indicates a potential upside of 167.02% from the company’s previous […]
More Stories
Cigna Group (NYSE:CI) Upgraded at TD Cowen
TD Cowen upgraded shares of Cigna Group (NYSE:CI – Free Report) to a strong-buy rating in a report released on...
JPMorgan Chase & Co. Begins Coverage on Carlisle Companies (NYSE:CSL)
Investment analysts at JPMorgan Chase & Co. initiated coverage on shares of Carlisle Companies (NYSE:CSL – Get Free Report) in...
Dollar General (NYSE:DG) Rating Lowered to Neutral at The Goldman Sachs Group
Dollar General (NYSE:DG – Get Free Report) was downgraded by stock analysts at The Goldman Sachs Group from a “buy”...
Analysts Set Expectations for Kroger’s Q2 Earnings (NYSE:KR)
The Kroger Co. (NYSE:KR – Free Report) – Equities researchers at Telsey Advisory Group reduced their Q2 2026 earnings per...
Research Analysts Issue Forecasts for Sealed Air Q2 Earnings
Sealed Air Corporation (NYSE:SEE – Free Report) – Stock analysts at Zacks Research dropped their Q2 2026 EPS estimates for...
Alphabet (NASDAQ:GOOGL) Trading Up 1.5% on Analyst Upgrade
Shares of Alphabet Inc. (NASDAQ:GOOGL – Get Free Report) were up 1.5% during mid-day trading on Tuesday after Citigroup raised...